All publications
2022
210: Endres M, Moro MA, Nolte CH, Dames C, Buckwalter MS, Meisel A. Immune Pathways in Etiology, Acute Phase, and Chronic Sequelae of Ischemic Stroke. Circ Res. 2022 Apr 15;130(8):1167-1186. doi: 10.1161/CIRCRESAHA.121.319994. Epub 2022 Apr 14. PMID: 35420915
209: Sánchez-Cruz A, Hernández-Pinto A, Lillo C, Isiegas C, Marchena M, Lizasoain I, Bosch F, de la Villa P, Hernández-Sánchez C, de la Rosa EJ. Insulin receptor activation by proinsulin preserves synapses and vision in retinitis pigmentosa. Cell Death Dis. 2022 Apr 20;13(4):383. doi: 10.1038/s41419-022-04839-0. PMID: 35444190
208: Hernández-Jiménez M, Martín-Vílchez S, Ochoa D, Mejía-Abril G, Román M, Camargo-Mamani P, Luquero-Bueno S, Jilma B, Moro MA, Fernández G, Piñeiro D, Ribó M, González VM, Lizasoain I, Abad-Santos F. First-in-human phase I clinical trial of a TLR4-binding DNA aptamer, ApTOLL: Safety and pharmacokinetics in healthy volunteers. Mol Ther Nucleic Acids. 2022 Mar 9;28:124-135. doi: 10.1016/j.omtn.2022.03.005. eCollection 2022 Jun 14. PMID: 35402075
207: Peña-Martínez C, Durán-Laforet V, García-Culebras A, Cuartero MI, Moro MÁ, Lizasoain I. Neutrophil Extracellular Trap Targeting Protects Against Ischemic Damage After Fibrin-Rich Thrombotic Stroke Despite Non-Reperfusion. Front Immunol. 2022 Feb 16;13:790002. doi: 10.3389/fimmu.2022.790002. eCollection 2022. PMID: 35250974
206: Gubern-Mérida C, Comajoan P, Huguet G, García-Yebenes I, Lizasoain I, Moro MA, Puig-Parnau I, Sánchez JM, Serena J, Kádár E, Castellanos M. Cav-1 Protein Levels in Serum and Infarcted Brain Correlate with Hemorrhagic Volume in a Mouse Model of Thromboembolic Stroke, Independently of rt-PA Administration. Mol Neurobiol. 2022 Feb;59(2):1320-1332. doi: 10.1007/s12035-021-02644-y. Epub 2022 Jan 5. PMID: 34984586
2021
205: Durán-Laforet V, Peña-Martínez C, García-Culebras A, Cuartero MI, Lo EH, Moro MÁ, Lizasoain I. Role of TLR4 in Neutrophil Dynamics and Functions: Contribution to Stroke Pathophysiology. Front Immunol. 2021 Oct 21;12:757872. doi: 10.3389/fimmu.2021.757872. eCollection 2021. PMID: 34745132
204: McCullough LD, Moro MA. Translational Interdisciplinary Science-Immune Cell Niches: Possible Targets for Stroke Therapy? Stroke. 2021 Nov;52(11):3692-3695. doi: 10.1161/STROKEAHA.121.033969. Epub 2021 Oct 8. PMID: 34619983
203: Durán-Laforet V, Peña-Martínez C, García-Culebras A, Alzamora L, Moro MA, Lizasoain I. Pathophysiological and pharmacological relevance of TLR4 in peripheral immune cells after stroke. Pharmacol Ther. 2021 Dec;228:107933. doi: 10.1016/j.pharmthera.2021.107933. Epub 2021 Jun 24. PMID: 34174279
202: Sánchez-Cruz A, Méndez AC, Lizasoain I, de la Villa P, de la Rosa EJ, Hernández-Sánchez C. Tlr2 Gene Deletion Delays Retinal Degeneration in Two Genetically Distinct Mouse Models of Retinitis Pigmentosa. Int J Mol Sci. 2021 Jul 22;22(15):7815. doi: 10.3390/ijms22157815. PMID: 34360582
201: Pradillo JM, Hernández-Jiménez M, Fernández-Valle ME, Medina V, Ortuño JE, Allan SM, Proctor SD, Garcia-Segura JM, Ledesma-Carbayo MJ, Santos A, Moro MA, Lizasoain I. Influence of metabolic syndrome on post-stroke outcome, angiogenesis and vascular function in old rats determined by dynamic contrast enhanced MRI. J Cereb Blood Flow Metab. 2021 Jul;41(7):1692-1706. doi: 10.1177/0271678X20976412. Epub 2020 Dec 1. PMID: 34152893
200: Lo EH, Albers GW, Dichgans M, Donnan G, Esposito E, Foster R, Howells DW, Huang YG, Ji X, Klerman EB, Lee S, Li W, Liebeskind DS, Lizasoain I, Mandeville ET, Moro MA, Ning M, Ray D, Sakadžić S, Saver JL, Scheer FAJL, Selim M, Tiedt S, Zhang F, Buchan AM. Circadian Biology and Stroke. Stroke. 2021 Jun;52(6):2180-2190. doi: 10.1161/STROKEAHA.120.031742. Epub 2021 May 4. PMID: 33940951
199: Cuartero MI, García-Culebras A, Torres-López C, Medina V, Fraga E, Vázquez-Reyes S, Jareño-Flores T, García-Segura JM, Lizasoain I, Moro MÁ. Post-stroke Neurogenesis: Friend or Foe? Front Cell Dev Biol. 2021 Mar 23;9:657846. doi: 10.3389/fcell.2021.657846. eCollection 2021. PMID: 33834025
198: Fernández-Ruiz J, de Lago E, Rodríguez-Cueto C, Moro MA. Recent advances in the pathogenesis and therapeutics of amyotrophic lateral sclerosis. Br J Pharmacol. 2021 Mar;178(6):1253-1256. doi: 10.1111/bph.15348. PMID: 33638898
197: Martínez-Miguel P, Albalate M, Durán-Laforet V, Peña-Martínez C, de Sequera P, Bouarich H, Peña-Esparragoza K, López-Ongil S, Lizasoain I, Sánchez-Prieto J, Torres M, Moro MÁ, Rodríguez-Puyol D. Effective glutamate clearance from the systemic circulation by hemodialysis: Potential relevance for cerebral ischemia management. Artif Organs. 2021 Oct;45(10):1183-1188. doi: 10.1111/aor.13933. Epub 2021 Mar 28. PMID: 33560549
196: Salobrar-García E, López-Cuenca I, Sánchez-Puebla L, de Hoz R, Fernández-Albarral JA, Ramírez AI, Bravo-Ferrer I, Medina V, Moro MA, Saido TC, Saito T, Salazar JJ, Ramírez JM. Retinal Thickness Changes Over Time in a Murine AD Model APP NL-F/NL-F. Front Aging Neurosci. 2021 Jan 15;12:625642. doi: 10.3389/fnagi.2020.625642. eCollection 2020. PMID: 33542683 Free PMC article
195: Boltze J, Aronowski JA, Badaut J, Buckwalter MS, Caleo M, Chopp M, Dave KR, Didwischus N, Dijkhuizen RM, Doeppner TR, Dreier JP, Fouad K, Gelderblom M, Gertz K, Golubczyk D, Gregson BA, Hamel E, Hanley DF, Härtig W, Hummel FC, Ikhsan M, Janowski M, Jolkkonen J, Karuppagounder SS, Keep RF, Koerte IK, Kokaia Z, Li P, Liu F, Lizasoain I, Ludewig P, Metz GAS, Montagne A, Obenaus A, Palumbo A, Pearl M, Perez-Pinzon M, Planas AM, Plesnila N, Raval AP, Rueger MA, Sansing LH, Sohrabji F, Stagg CJ, Stetler RA, Stowe AM, Sun D, Taguchi A, Tanter M, Vay SU, Vemuganti R, Vivien D, Walczak P, Wang J, Xiong Y, Zille M. New Mechanistic Insights, Novel Treatment Paradigms, and Clinical Progress in Cerebrovascular Diseases. Front Aging Neurosci. 2021 Jan 28;13:623751. doi: 10.3389/fnagi.2021.623751. eCollection 2021. PMID: 33584250
2020
194: Adrover JM, Aroca-Crevillén A, Crainiciuc G, Ostos F, Rojas-Vega Y, Rubio-Ponce A, Cilloniz C, Bonzón-Kulichenko E, Calvo E, Rico D, Moro MA, Weber C, Lizasoain I, Torres A, Ruiz-Cabello J, Vázquez J, Hidalgo A. Programmed 'disarming' of the neutrophil proteome reduces the magnitude of inflammation. Nat Immunol. 2020 Jan 13. doi: 10.1038/s41590-019-0571-2. PubMed PMID: 31932813
2019
193: Peña-Martínez C, Durán-Laforet V, García-Culebras A, Ostos F, Hernández-Jiménez M, Bravo-Ferrer I, Pérez-Ruiz A, Ballenilla F, Díaz-Guzmán J, Pradillo JM, Lizasoain I, Moro MA. Pharmacological Modulation of Neutrophil Extracellular Traps Reverses Thrombotic Stroke tPA (Tissue-Type Plasminogen Activator) Resistance. Stroke. 2019 Nov;50(11):3228-3237. doi:10.1161/STROKEAHA.119.026848. PubMed PMID: 31526124.
192: Bravo-Ferrer I, Cuartero MI, Medina V, Ahedo-Quero D, Peña-Martínez C, Pérez-Ruíz A, Fernández-Valle ME, Hernández-Sánchez C, Fernández-Salguero PM, Lizasoain I, Moro MA. Lack of the aryl hydrocarbon receptor accelerates aging in mice. FASEB J. 2019 Nov;33(11):12644-12654. doi: 10.1096/fj.201901333R. PubMed PMID: 31483997.
191: García-Culebras A, Durán-Laforet V, Peña-Martínez C, Moraga A, Ballesteros I, Cuartero MI, de la Parra J, Palma-Tortosa S, Hidalgo A, Corbí AL, Moro MA, Lizasoain I. Role of TLR4 (Toll-Like Receptor 4) in N1/N2 Neutrophil Programming After Stroke. Stroke. 2019 Oct;50(10):2922-2932. doi: 10.1161/STROKEAHA.119.025085. PubMed PMID: 31451099.
190: Durán-Laforet V, Fernández-López D, García-Culebras A, González-Hijón J, Moraga A, Palma-Tortosa S, García-Yébenes I, Vega-Pérez A, Lizasoain I, Moro MÁ. Delayed Effects of Acute Reperfusion on Vascular Remodeling and Late-Phase Functional Recovery After Stroke. Front Neurosci. 2019 Jul 23;13:767. doi: 10.3389/fnins.2019.00767. PubMed PMID: 31396042.
189: Palma-Tortosa S, Hurtado O, Pradillo JM, Ferreras-Martín R, García-Yébenes I, García-Culebras A, Moraga A, Moro MÁ, Lizasoain I. Toll-like receptor 4 regulates subventricular zone proliferation and neuroblast migration after experimental stroke. Brain Behav Immun. 2019 Aug;80:573-582. doi: 10.1016/j.bbi.2019.05.002. PubMed PMID: 31059808.
188: Cuartero MI, de la Parra J, Pérez-Ruiz A, Bravo-Ferrer I, Durán-Laforet V, García-Culebras A, García-Segura JM, Dhaliwal J, Frankland PW, Lizasoain I, Moro MÁ. Abolition of aberrant neurogenesis ameliorates cognitive impairment after stroke in mice. J Clin Invest. 2019 Apr 1;129(4):1536-1550. doi: 10.1172/JCI120412. PubMed PMID: 30676325.
187: Adrover JM, Del Fresno C, Crainiciuc G, Cuartero MI, Casanova-Acebes M, Weiss LA, Huerga-Encabo H, Silvestre-Roig C, Rossaint J, Cossío I, Lechuga-Vieco AV, García-Prieto J, Gómez-Parrizas M, Quintana JA, Ballesteros I, Martin-Salamanca S, Aroca-Crevillen A, Chong SZ, Evrard M, Balabanian K, López J, Bidzhekov K, Bachelerie F, Abad-Santos F, Muñoz-Calleja C, Zarbock A, Soehnlein O, Weber C, Ng LG, Lopez-Rodriguez C, Sancho D, Moro MA, Ibáñez B, Hidalgo A. A Neutrophil Timer Coordinates Immune Defense and Vascular Protection. Immunity. 2019 Feb 19;50(2):390-402.e10. doi: 10.1016/j.immuni.2019.01.002.Erratum in: Immunity. 2019 Nov 19;51(5):966-967. PubMed PMID: 30709741.
2018
186: de la Parra J, Cuartero MI, Pérez-Ruiz A, García-Culebras A, Martín R, Sánchez-Prieto J, García-Segura JM, Lizasoain I, Moro MA. AhR Deletion Promotes Aberrant Morphogenesis and Synaptic Activity of Adult-Generated Granule Neurons and Impairs Hippocampus-Dependent Memory. eNeuro. 2018 Aug 22;5(4). doi: 10.1523/ENEURO.0370-17.2018. PubMed PMID: 30225360; PubMed Central PMCID: PMC6140122.
185: García-Culebras A, Durán-Laforet V, Peña-Martínez C, Ballesteros I, Pradillo JM, Díaz-Guzmán J, Lizasoain I, Moro MA. Myeloid cells as therapeutic targets in neuroinflammation after stroke: Specific roles of neutrophils and neutrophil-platelet interactions. J Cereb Blood Flow Metab. 2018 Dec;38(12):2150-2164. doi: 10.1177/0271678X18795789. PubMed PMID: 30129391.
184: García-Yébenes I, García-Culebras A, Peña-Martínez C, Fernández-López D, Díaz-Guzmán J, Negredo P, Avendaño C, Castellanos M, Gasull T, Dávalos A, Moro MA, Lizasoain I. Iron Overload Exacerbates the Risk of Hemorrhagic Transformation After tPA (Tissue-Type Plasminogen Activator) Administration in Thromboembolic Stroke Mice. Stroke. 2018 Sep;49(9):2163-2172. doi: 10.1161/STROKEAHA.118.021540. PubMed PMID: 30018160.
183: Fernández G, Moraga A, Cuartero MI, García-Culebras A, Peña-Martínez C, Pradillo JM, Hernández-Jiménez M, Sacristán S, Ayuso MI, Gonzalo-Gobernado R, Fernández-López D, Martín ME, Moro MA, González VM, Lizasoain I. TLR4-Binding DNA Aptamers Show a Protective Effect against Acute Stroke in Animal Models. Mol Ther. 2018 Aug 1;26(8):2047-2059. doi: 10.1016/j.ymthe.2018.05.019. PubMed PMID: 29910175.
182: Sánchez-Cruz A, Villarejo-Zori B, Marchena M, Zaldivar-Díez J, Palomo V, Gil C, Lizasoain I, de la Villa P, Martínez A, de la Rosa EJ, Hernández-Sánchez C. Modulation of GSK-3 provides cellular and functional neuroprotection in the rd10 mouse model of retinitis pigmentosa. Mol Neurodegener. 2018 Apr 16;13(1):19. doi: 10.1186/s13024-018-0251-y. PubMed PMID: 29661219.
181: DeGregorio-Rocasolano N, Martí-Sistac O, Ponce J, Castelló-Ruiz M, Millán M, Guirao V, García-Yébenes I, Salom JB, Ramos-Cabrer P, Alborch E, Lizasoain I, Castillo J, Dávalos A, Gasull T. Iron-loaded transferrin (Tf) is detrimental whereas iron-free Tf confers protection against brain ischemia by modifying blood Tf saturation and subsequent neuronal damage. Redox Biol. 2018 May;15:143-158. doi: 10.1016/j.redox.2017.11.026. PubMed PMID: 29248829.
2017
180: Palma-Tortosa S, García-Culebras A, Moraga A, Hurtado O, Perez-Ruiz A, Durán-Laforet V, Parra J, Cuartero MI, Pradillo JM, Moro MA, Lizasoain I. Specific Features of SVZ Neurogenesis After Cortical Ischemia: a Longitudinal Study. Sci Rep. 2017 Nov 27;7(1):16343. doi: 10.1038/s41598-017-16109-7. PubMed PMID: 29180821.
179: Hernández-Jiménez M, Peña-Martínez C, Godino MDC, Díaz-Guzmán J, Moro MÁ, Lizasoain I. Test repositioning for functional assessment of neurological outcome after experimental stroke in mice. PLoS One. 2017 May 4;12(5):e0176770. doi: 10.1371/journal.pone.0176770. PubMed PMID: 28472090.
178: García-Culebras A, Palma-Tortosa S, Moraga A, García-Yébenes I, Durán-Laforet V, Cuartero MI, de la Parra J, Barrios-Muñoz AL, Díaz-Guzmán J, Pradillo JM, Moro MA, Lizasoain I. Toll-Like Receptor 4 Mediates Hemorrhagic Transformation After Delayed Tissue Plasminogen Activator Administration in In Situ Thromboembolic Stroke. Stroke. 2017 Jun;48(6):1695-1699. doi: 10.1161/STROKEAHA.116.015956. PubMed PMID: 28428349.
177: Bravo-Ferrer I, Cuartero MI, Zarruk JG, Pradillo JM, Hurtado O, Romera VG, Díaz-Alonso J, García-Segura JM, Guzmán M, Lizasoain I, Galve-Roperh I, Moro MA. Cannabinoid Type-2 Receptor Drives Neurogenesis and Improves Functional Outcome After Stroke. Stroke. 2017 Jan;48(1):204-212. doi: 10.1161/STROKEAHA.116.014793. PubMed PMID: 27899748.
176: Pradillo JM, Murray KN, Coutts GA, Moraga A, Oroz-Gonjar F, Boutin H, Moro MA, Lizasoain I, Rothwell NJ, Allan SM. Reparative effects of interleukin-1 receptor antagonist in young and aged/co-morbid rodents after cerebral ischemia. Brain Behav Immun. 2017 Mar;61:117-126. doi: 10.1016/j.bbi.2016.11.013. PubMed PMID: 27856349.
2016
175: Orset C, Haelewyn B, Allan SM, Ansar S, Campos F, Cho TH, Durand A, El Amki M, Fatar M, Garcia-Yébenes I, Gauberti M, Grudzenski S, Lizasoain I, Lo E, Macrez R, Margaill I, Maysami S, Meairs S, Nighoghossian N, Orbe J, Paramo JA, Parienti JJ, Rothwell NJ, Rubio M, Waeber C, Young AR, Touzé E, Vivien D. Efficacy of Alteplase in a Mouse Model of Acute Ischemic Stroke: A Retrospective Pooled Analysis. Stroke. 2016 May;47(5):1312-1318. doi: 10.1161/STROKEAHA.116.012238. PubMed PMID: 27032444.
174: Moraga A, Gómez-Vallejo V, Cuartero MI, Szczupak B, San Sebastián E, Markuerkiaga I, Pradillo JM, Higuchi M, Llop J, Moro MÁ, Martín A, Lizasoain I. Imaging the role of toll-like receptor 4 on cell proliferation and inflammation after cerebral ischemia by positron emission tomography. J Cereb Blood Flow Metab. 2016 Apr;36(4):702-8. doi: 10.1177/0271678X15627657. PubMed PMID: 26787106.
173: Hernández-Jiménez M, Martínez-López D, Gabandé-Rodríguez E, Martín-Segura A, Lizasoain I, Ledesma MD, Dotti CG, Moro MA. Seladin-1/DHCR24 Is Neuroprotective by Associating EAAT2 Glutamate Transporter to Lipid Rafts in Experimental Stroke. Stroke. 2016 Jan;47(1):206-13. doi: 10.1161/STROKEAHA.115.010810. PubMed PMID: 26628388.
172: Maysami S, Wong R, Pradillo JM, Denes A, Dhungana H, Malm T, Koistinaho J, Orset C, Rahman M, Rubio M, Schwaninger M, Vivien D, Bath PM, Rothwell NJ, Allan SM. A cross-laboratory preclinical study on the effectiveness of interleukin-1 receptor antagonist in stroke. J Cereb Blood Flow Metab. 2016 Mar;36(3): 596-605. doi: 10.1177/0271678X15606714. PubMed PMID: 26661169
171: Diane A, Pierce WD, Kelly SE, Sokolic S, Borthwick F, Jacome-Sosa M, Mangat R, Pradillo JM, Allan SM, Ruth MR, Field CJ, Hutcheson R, Rocic P, Russell JC, Vine DF, Proctor SP. Mechanisms of Comorbidities Associated With the Metabolic Syndrome: Insights from the JCR: LA-cp Corpulent Rat Strain. Front Nutr. 2016 Oct 10;3:44 pp. 1-12. doi: 10.3389/fnut.2016.00044.
170: Cuartero MI, de la Parra J, García-Culebras A, Ballesteros I, Lizasoain I, Moro MÁ. The Kynurenine Pathway in the Acute and Chronic Phases of Cerebral Ischemia. Curr Pharm Des. 2016;22(8):1060-73. Review. PubMed PMID: 25248805.
2015
169: Nieto E, Delgado M, Sobrado M, de Ceballos ML, Alajarín R, García-García L, Kelly J, Lizasoain I, Pozo MA, Álvarez-Builla J. Preliminary research on 1-(4-bromo-2-nitroimidazol-1-yl)-3-[(18)F]fluoropropan-2-ol as a novel brain hypoxia PET tracer in a rodent model of stroke. Eur J Med Chem. 2015 Aug 28;101:604-15. doi: 10.1016/j.ejmech.2015.06.023. PubMed PMID: 26204508.
168: Amantea D, Micieli G, Tassorelli C, Cuartero MI, Ballesteros I, Certo M, Moro MA, Lizasoain I, Bagetta G. Rational modulation of the innate immune system for neuroprotection in ischemic stroke. Front Neurosci. 2015 Apr 29;9:147. doi: 10.3389/fnins.2015.00147. PubMed PMID: 25972779.
167: Moraga A, Pradillo JM, García-Culebras A, Palma-Tortosa S, Ballesteros I, Hernández-Jiménez M, Moro MA, Lizasoain I. Aging increases microglial proliferation, delays cell migration, and decreases cortical neurogenesis after focal cerebral ischemia. J Neuroinflammation. 2015 May 10;12:87. doi:10.1186/s12974-015-0314-8. PubMed PMID: 25958332.
166: Cuartero MI, Ballesteros I, Lizasoain I, Moro MA. Complexity of the cell-cell interactions in the innate immune response after cerebral ischemia. Brain Res. 2015 Oct 14;1623:53-62. doi: 10.1016/j.brainres.2015.04.047. PubMed PMID: 25956207.
165: Fernández-Ruiz J, Moro MA, Martínez-Orgado J. Cannabinoids inNeurodegenerative Disorders and Stroke/Brain Trauma: From Preclinical Models to Clinical Applications. Neurotherapeutics. 2015 Oct;12(4):793-806. doi: 10.1007/s13311-015-0381-7. PubMed PMID: 26260390.
2014
164: Ballesteros I, Cuartero MI, Moraga A, de la Parra J, Lizasoain I, Moro MÁ. Stereological and flow cytometry characterization of leukocyte subpopulations in models of transient or permanent cerebral ischemia. J Vis Exp. 2014 Dec 28;(94). doi: 10.3791/52031. PubMed PMID: 25590380.
163: Sreeramkumar V, Adrover JM, Ballesteros I, Cuartero MI, Rossaint J, Bilbao I, Nácher M, Pitaval C, Radovanovic I, Fukui Y, McEver RP, Filippi MD, Lizasoain I, Ruiz-Cabello J, Zarbock A, Moro MA, Hidalgo A. Neutrophils scan for activated platelets to initiate inflammation. Science. 2014 Dec 5;346(6214):1234-8. doi: 10.1126/science.1256478. PubMed PMID: 25477463.
162: Cuartero MI, Ballesteros I, de la Parra J, Harkin AL, Abautret-Daly A, Sherwin E, Fernández-Salguero P, Corbí AL, Lizasoain I, Moro MA. L-kynurenine/aryl hydrocarbon receptor pathway mediates brain damage after experimental stroke. Circulation. 2014 Dec 2;130(23):2040-51. doi: 10.1161/CIRCULATIONAHA.114.011394. PubMed PMID: 25359166.
161: Moraga A, Pradillo JM, Cuartero MI, Hernández-Jiménez M, Oses M, Moro MA, Lizasoain I. Toll-like receptor 4 modulates cell migration and cortical neurogenesis after focal cerebral ischemia. FASEB J. 2014 Nov;28(11):4710-8. doi: 10.1096/fj.14-252452. PubMed PMID: 25063846.
160: Camós S, Gubern C, Sobrado M, Rodríguez R, Romera VG, Moro MA, Lizasoain I, Serena J, Mallolas J, Castellanos M. The high-mobility group I-Y transcription factor is involved in cerebral ischemia and modulates the expression of angiogenic proteins. Neuroscience. 2014 Jun 6;269:112-30. doi: 10.1016/j.neuroscience.2014.03.036. PubMed PMID: 24680881.
159: Gubern C, Camós S, Hurtado O, Rodríguez R, Romera VG, Sobrado M, Cañadas R, Moro MA, Lizasoain I, Serena J, Mallolas J, Castellanos M. Characterization of Gcf2/Lrrfip1 in experimental cerebral ischemia and its role as a modulator of Akt, mTOR and β-catenin signaling pathways. Neuroscience. 2014 May 30;268:48-65. doi: 10.1016/j.neuroscience.2014.02.051. PubMed PMID: 24637094.
158: Ballesteros I, Cuartero MI, Pradillo JM, de la Parra J, Pérez-Ruiz A, Corbí A, Ricote M, Hamilton JA, Sobrado M, Vivancos J, Nombela F, Lizasoain I, Moro MA. Rosiglitazone-induced CD36 up-regulation resolves inflammation by PPARγ and 5-LO-dependent pathways. J Leukoc Biol. 2014 Apr;95(4):587-98. doi: 10.1189/jlb.0613326. PubMed PMID: 24338629.
157: Camós S, Gubern C, Sobrado M, Rodríguez R, Romera VG, Moro MÁ, Lizasoain I, Serena J, Mallolas J, Castellanos M. Oct-2 transcription factor binding activity and expression up-regulation in rat cerebral ischaemia is associated with a diminution of neuronal damage in vitro. Neuromolecular Med. 2014 Jun;16(2):332-49. doi: 10.1007/s12017-013-8279-1. PubMed PMID:24282026.
156: Domínguez-Soto A, de las Casas-Engel M, Bragado R, Medina-Echeverz J, Aragoneses-Fenoll L, Martín-Gayo E, van Rooijen N, Berraondo P, Toribio ML, Moro MA, Cuartero I, Castrillo A, Sancho D, Sánchez-Torres C, Bruhns P, Sánchez-Ramón S, Corbí AL. Intravenous immunoglobulin promotes antitumor responses by modulating macrophage polarization. J Immunol. 2014 Nov 15;193(10):5181-9. doi: 10.4049/jimmunol.1303375. PubMed PMID: 25326025.
155: Dénes Á, Pradillo JM, Drake C, Sharp A, Warn P, Murray KN, Rohit B, Dockrell DH, Chamberlain J, Casbolt H, Francis S, Martinecz B, Nieswandt B, Rothwell NJ, Allan SM. Streptococcus pneumoniae worsens cerebral ischemia via interleukin 1 and platelet glycoprotein Ibα. Ann Neurol. 2014 May;75(5):670-83. doi: 10.1002/ana.24146. PubMed PMID: 24644058.
154: Fernández-López D, Natarajan N, Ashwal S, Vexler ZS. Mechanisms of perinatal arterial ischemic stroke. J Cereb Blood Flow Metab. 2014 Jun;34(6):921-32. doi: 10.1038/jcbfm.2014.41. PubMed PMID: 24667913.
2013
153: Cuartero MI, Ballesteros I, Moraga A, Nombela F, Vivancos J, Hamilton JA, Corbí ÁL, Lizasoain I, Moro MA. N2 neutrophils, novel players in brain inflammation after stroke: modulation by the PPARγ agonist rosiglitazone. Stroke. 2013 Dec;44(12):3498-508. doi: 10.1161/STROKEAHA.113.002470. PubMed PMID: 24135932.
152: Gubern C, Camós S, Ballesteros I, Rodríguez R, Romera VG, Cañadas R, Lizasoain I, Moro MA, Serena J, Mallolas J, Castellanos M. miRNA expression is modulated over time after focal ischaemia: up-regulation of miR-347 promotes neuronal apoptosis. FEBS J. 2013 Dec;280(23):6233-46. doi: 10.1111/febs.12546. PubMed PMID: 24112606.
151: Godino Mdel C, Romera VG, Sánchez-Tomero JA, Pacheco J, Canals S, Lerma J, Vivancos J, Moro MA, Torres M, Lizasoain I, Sánchez-Prieto J. Amelioration of ischemic brain damage by peritoneal dialysis. J Clin Invest. 2013 Oct;123(10):4359-63. doi: 10.1172/JCI67284. PubMed PMID: 23999426.
150: Hernández-Jiménez M, Hurtado O, Cuartero MI, Ballesteros I, Moraga A, Pradillo JM, McBurney MW, Lizasoain I, Moro MA. Silent information regulator 1 protects the brain against cerebral ischemic damage. Stroke. 2013 Aug;44(8):2333-7. doi: 10.1161/STROKEAHA.113.001715. PubMed PMID: 23723308.
149: Hurtado O, Hernández-Jiménez M, Zarruk JG, Cuartero MI, Ballesteros I, Camarero G, Moraga A, Pradillo JM, Moro MA, Lizasoain I. Citicoline (CDP-choline) increases Sirtuin1 expression concomitant to neuroprotection in experimental stroke. J Neurochem. 2013 Sep;126(6):819-26. doi: 10.1111/jnc.12269. PubMed PMID: 23600725.
148: Nombela F, Blanco M, Pérez de la Ossa N, Caniego JL, Sobrino T, Escudero D, Campos F, Moro MÁ, Lizasoaín I, Dávalos A, Castillo J, Vivancos J. Neuronal excitotoxicity after carotid angioplasty and stent placement procedures. Radiology. 2013 Aug;268(2):515-20. doi: 10.1148/radiol.13112104. PubMed PMID: 23525205.
147: Fernández-López D, Lizasoain I, Moro MA, Martínez-Orgado J. Cannabinoids: well-suited candidates for the treatment of perinatal brain injury. Brain Sci. 2013 Jul 10;3(3):1043-59. doi: 10.3390/brainsci3031043. PubMed PMID: 24961520.
146: Faraco G, Moraga A, Moore J, Anrather J, Pickel VM, Iadecola C. Circulating endothelin-1 alters critical mechanisms regulating cerebral microcirculation. Hypertension. 2013 Oct;62(4):759-66. doi: 10.1161/HYPERTENSIONAHA.113.01761.
145: Smith CJ, Lawrence CB, Rodriguez-Grande B, Kovacs KJ, Pradillo JM, Denes A. The immune system in stroke: clinical challenges and their translation to experimental research. J Neuroimmune Pharmacol. 2013 Sep;8(4):867-87. doi: 10.1007/s11481-013-9469-1.
2012
144: García-Yébenes I, Sobrado M, Moraga A, Zarruk JG, Romera VG, Pradillo JM, Perez de la Ossa N, Moro MA, Dávalos A, Lizasoain I. Iron overload, measured as serum ferritin, increases brain damage induced by focal ischemia and early reperfusion. Neurochem Int. 2012 Dec;61(8):1364-9. doi: 10.1016/j.neuint.2012.09.014. Epub 2012 Oct 2. PubMed PMID: 23036361.
143: Hurtado O, Ballesteros I, Cuartero MI, Moraga A, Pradillo JM, Ramírez-Franco J, Bartolomé-Martín D, Pascual D, Torres M, Sánchez-Prieto J, Salom JB, Lizasoain I, Moro MA. Daidzein has neuroprotective effects through ligand-binding-independent PPARγ activation. Neurochem Int. 2012 Jul;61(1):119-27. doi: 10.1016/j.neuint.2012.04.007. PubMed PMID: 22521773.
142: Sobrado M, Ramirez BG, Neria F, Lizasoain I, Arbones ML, Minami T, Redondo JM, Moro MA, Cano E. Regulator of calcineurin 1 (Rcan1) has a protective role in brain ischemia/reperfusion injury. J Neuroinflammation. 2012 Mar 7;9:48. doi: 10.1186/1742-2094-9-48. PubMed PMID: 22397398.
141: Fernández-López D, Faustino J, Derugin N, Wendland M, Lizasoain I, Moro MA, Vexler ZS. Reduced infarct size and accumulation of microglia in rats treated with WIN 55,212-2 after neonatal stroke. Neuroscience. 2012 Apr 5;207:307-15. doi: 10.1016/j.neuroscience.2012.01.008. PubMed PMID: 22285309.
140: Redondo M, Zarruk JG, Ceballos P, Pérez DI, Pérez C, Perez-Castillo A, Moro MA, Brea J, Val C, Cadavid MI, Loza MI, Campillo NE, Martínez A, Gil C. Neuroprotective efficacy of quinazoline type phosphodiesterase 7 inhibitors in cellular cultures and experimental stroke model. Eur J Med Chem. 2012 Jan;47(1):175-85. doi: 10.1016/j.ejmech.2011.10.040. PubMed PMID: 22100138.
139: Zarruk JG, Fernández-López D, García-Yébenes I, García-Gutiérrez MS, Vivancos J, Nombela F, Torres M, Burguete MC, Manzanares J, Lizasoain I, Moro MA. Cannabinoid type 2 receptor activation downregulates stroke-induced classic and alternative brain macrophage/microglial activation concomitant to neuroprotection. Stroke. 2012 Jan;43(1):211-9. doi: 10.1161/STROKEAHA.111.631044. PubMed PMID: 22020035.
138: Lopez-Jimenez ME, González JC, Lizasoain I, Sánchez-Prieto J, Hernández-Guijo JM, Torres M. Functional cGMP-gated channels in cerebellar granule cells. J Cell Physiol. 2012 May;227(5):2252-63. doi: 10.1002/jcp.22964. PubMed PMID: 21809342.
2011
137: Zarruk JG, Garcia-Yebenes I, Romera VG, Ballesteros I, Moraga A, Cuartero MI, Hurtado O, Sobrado M, Pradillo JM, Fernandez-Lopez D, Serena J, Castillo-Melendez M, Moro MA, Lizasoain I. Neurological tests for functional outcome assessment in rodent models of ischaemic stroke. Rev Neurol. 2011 Nov 16;53(10):607-18. PubMed PMID: 22052176.
136: Bustamante MF, Fissolo N, Río J, Espejo C, Costa C, Mansilla MJ, Lizasoain I, Moro MA, Carmen Edo M, Montalban X, Comabella M. Implication of the Toll-like receptor 4 pathway in the response to interferon-β in multiple sclerosis. AnnNeurol. 2011 Oct;70(4):634-45. doi: 10.1002/ana.22511. PubMed PMID: 22028223.
135: Sobrado M, Delgado M, Fernández-Valle E, García-García L, Torres M, Sánchez-Prieto J, Vivancos J, Manzanares R, Moro MA, Pozo MA, Lizasoain I. Longitudinal studies of ischemic penumbra by using 18F-FDG PET and MRI techniques in permanent and transient focal cerebral ischemia in rats. Neuroimage. 2011 Jul 1;57(1):45-54. doi: 10.1016/j.neuroimage.2011.04.045. PubMed PMID: 21549205.
134: Hurtado O, Lizasoain I, Moro MÁ. Neuroprotection and recovery: recent data at the bench on citicoline. Stroke. 2011 Jan;42(1 Suppl):S33-5. doi: 10.1161/STROKEAHA.110.597435. Epub 2010 Dec 16. PubMed PMID: 21164125.
133: García-Yébenes I, Sobrado M, Zarruk JG, Castellanos M, Pérez de la Ossa N, Dávalos A, Serena J, Lizasoain I, Moro MA. A mouse model of hemorrhagic transformation by delayed tissue plasminogen activator administration after in situ thromboembolic stroke. Stroke. 2011 Jan;42(1):196-203. doi: 10.1161/STROKEAHA.110.600452. PubMed PMID: 21106952.
132: Rodríguez-González R, Sobrino T, Millán M, Miranda E, Brea D, Cristobo I, Blanco M, Pérez J, Pumar JM, Castellanos M, Lomas D, Moro MA, Dávalos A, Castillo J.The natural tissue plasminogen activator inhibitor neuroserpin and acute ischemic stroke outcome. Thromb. Haemost. 2011 Mar;105(3):421-9. doi: 10.1160/TH10-09-0621. PubMed PMID: 21174006.
2010
131: Fernández-López D, Pradillo JM, García-Yébenes I, Martínez-Orgado JA, Moro MA, Lizasoain I. The cannabinoid WIN55212-2 promotes neural repair after neonatal hypoxia-ischemia. Stroke. 2010 Dec;41(12):2956-64. doi: 10.1161/STROKEAHA.110.599357. PubMed PMID: 21115947.
130: Hurtado O, Serrano J, Sobrado M, Fernández AP, Lizasoain I, Martínez-Murillo R, Moro MA, Martínez A. Lack of adrenomedullin, but not complement factor H, results in larger infarct size and more extensive brain damage in a focal ischemia model. Neuroscience. 2010 Dec 15;171(3):885-92. doi: 10.1016/j.neuroscience.2010.09.021. PubMed PMID: 20854881.
129: Marrachelli VG, Miranda FJ, Centeno JM, Salom JB, Torregrosa G, Jover-Mengual T, Pérez AM, Moro MA, Alborch E. Role of NO-synthases and cyclooxygenases in the hyperreactivity of male rabbit carotid artery to testosterone under experimental diabetes. Pharmacol Res. 2010 Jan;61(1):62-70. doi: 10.1016/j.phrs.2009.06.008. PubMed PMID: 19573602.
2009
128: Bolaños JP, Moro MA, Lizasoain I, Almeida A. Mitochondria and reactive oxygen and nitrogen species in neurological disorders and stroke: Therapeutic implications. Adv Drug Deliv Rev. 2009 Nov 30;61(14):1299-315. doi: 10.1016/j.addr.2009.05.009. PubMed PMID: 19716390.
127: Comabella M, Pradillo JM, Fernández M, Río J, Lizasoain I, Julià E, Moro MA, Sastre-Garriga J, Montalban X. Plasma levels of 15d-PGJ are not altered in multiple sclerosis. Eur J Neurol. 2009 Nov;16(11):1197-201. doi: 10.1111/j.1468-1331.2009.02696.x. PubMed PMID: 19538219.
126: Gubern C, Hurtado O, Rodríguez R, Morales JR, Romera VG, Moro MA, Lizasoain I, Serena J, Mallolas J. Validation of housekeeping genes for quantitative real-time PCR in in-vivo and in-vitro models of cerebral ischaemia. BMC Mol Biol. 2009 Jun 16;10:57. doi: 10.1186/1471-2199-10-57. PubMed PMID: 19531214; PubMed.
125: Sobrado M, Pereira MP, Ballesteros I, Hurtado O, Fernández-López D, Pradillo JM, Caso JR, Vivancos J, Nombela F, Serena J, Lizasoain I, Moro MA. Synthesis of lipoxin A4 by 5-lipoxygenase mediates PPARgamma-dependent, neuroprotective effects of rosiglitazone in experimental stroke. J Neurosci. 2009 Mar25;29(12):3875-84. doi: 10.1523/JNEUROSCI.5529-08.2009. PubMed PMID: 19321784.
124: Pradillo JM, Fernández-López D, García-Yébenes I, Sobrado M, Hurtado O, Moro MA, Lizasoain I. Toll-like receptor 4 is involved in neuroprotection afforded by ischemic preconditioning. J Neurochem. 2009 Apr;109(1):287-94. doi:10.1111/j.1471-4159.2009.05972.x. PubMed PMID: 19200341.
123: Caso JR, Hurtado O, Pereira MP, García-Bueno B, Menchén L, Alou L, Gómez-Lus ML, Moro MA, Lizasoain I, Leza JC. Colonic bacterial translocation as a possible factor in stress-worsening experimental stroke outcome. Am J Physiol Regul Integr Comp Physiol. 2009 Apr;296(4):R979-85. doi: 10.1152/ajpregu.90825.2008. PubMed PMID: 19193944.
122: Pastor MD, García-Yébenes I, Fradejas N, Pérez-Ortiz JM, Mora-Lee S, Tranque P, Moro MA, Pende M, Calvo S. mTOR/S6 kinase pathway contributes to astrocyte survival during ischemia. J Biol Chem. 2009 Aug 14;284(33):22067-78. doi:10.1074/jbc.M109.033100. PubMed PMID: 19535330.
121: Barros CA, Ekuni R, Moro MA, Pereira FM, Dos Santos Pereira MA, Milani H. The cognitive and histopathological effects of chronic 4-vessel occlusion in rats depend on the set of vessels occluded and the age of the animals. Behav Brain Res. 2009 Feb 11;197(2):378-87. doi: 10.1016/j.bbr.2008.10.023. PubMed PMID: 19007820.
2008
120: Eisenberg G, Pradillo J, Plaza G, Lizasoain I, Moro MA. [Increased expression and activity of MMP-9 in chronic rhinosinusitis with nasal polyposis]. ActaOtorrinolaringol Esp. 2008 Nov;59(9):444-7. PubMed PMID: 19080775.
119: Morales JR, Ballesteros I, Deniz JM, Hurtado O, Vivancos J, Nombela F, Lizasoain I, Castrillo A, Moro MA. Activation of liver X receptors promotes neuroprotection and reduces brain inflammation in experimental stroke. Circulation. 2008 Sep 30;118(14):1450-9. doi: 10.1161/CIRCULATIONAHA.108.782300. PubMed PMID: 18794391.
118: Caso JR, Pradillo JM, Hurtado O, Leza JC, Moro MA, Lizasoain I. Toll-like receptor 4 is involved in subacute stress-induced neuroinflammation and in the worsening of experimental stroke. Stroke. 2008 Apr;39(4):1314-20. doi: 10.1161/STROKEAHA.107.498212. PubMed PMID: 18309167.
117: Salom JB, Castelló-Ruiz M, Burguete MC, Guzmán C, Jover-Mengual T, Torregrosa G, Jover R, Lizasoain I, Alborch E. Role of K+ and Ca2+ fluxes in the cerebroarterial vasoactive effects of sildenafil. Eur J Pharmacol. 2008 Feb26;581(1-2):138-47. PubMed PMID: 18155692.
116: Hurtado O, Pradillo JM, Fernández-López D, Morales JR, Sobrino T, Castillo J, Alborch E, Moro MA, Lizasoain I. Delayed post-ischemic administration of CDP-choline increases EAAT2 association to lipid rafts and affords neuroprotection in experimental stroke. Neurobiol Dis. 2008 Jan;29(1):123-31. PubMed PMID: 17884513.
2007
115: Martínez-Orgado J, Fernández-López D, Lizasoain I, Romero J. The seek of neuroprotection: introducing cannabinoids. Recent Pat CNS Drug Discov. 2007 Jun;2(2):131-9. PubMed PMID: 18221224.
114: Sobrino T, Hurtado O, Moro MA, Rodríguez-Yáñez M, Castellanos M, Brea D, Moldes O, Blanco M, Arenillas JF, Leira R, Dávalos A, Lizasoain I, Castillo J. The increase of circulating endothelial progenitor cells after acute ischemic stroke is associated with good outcome. Stroke. 2007 Oct;38(10):2759-64. PubMed PMID: 17761925.
113: Blanco M, Nombela F, Castellanos M, Rodriguez-Yáñez M, García-Gil M, Leira R, Lizasoain I, Serena J, Vivancos J, Moro MA, Dávalos A, Castillo J. Statin treatment withdrawal in ischemic stroke: a controlled randomized study. Neurology. 2007 Aug 28;69(9):904-10. PubMed PMID: 17724294.
112: Fernández-López D, Pazos MR, Tolón RM, Moro MA, Romero J, Lizasoain I, Martínez-Orgado J. The cannabinoid agonist WIN55212 reduces brain damage in an in vivo model of hypoxic-ischemic encephalopathy in newborn rats. Pediatr Res. 2007 Sep;62(3):255-60. PubMed PMID: 17622949.
111: Ponferrada A, Caso JR, Alou L, Colón A, Sevillano D, Moro MA, Lizasoain I, Menchén P, Gómez-Lus ML, Lorenzo P, Cos E, Leza JC, Menchén L. The role of PPARgamma on restoration of colonic homeostasis after experimental stress-induced inflammation and dysfunction. Gastroenterology. 2007 May;132(5):1791-803. PubMed PMID: 17484875.
110: Caso JR, Pradillo JM, Hurtado O, Lorenzo P, Moro MA, Lizasoain I. Toll-like receptor 4 is involved in brain damage and inflammation after experimental stroke. Circulation. 2007 Mar 27;115(12):1599-608. PubMed PMID: 17372179.
109: Caso JR, Moro MA, Lorenzo P, Lizasoain I, Leza JC. Involvement of IL-1beta in acute stress-induced worsening of cerebral ischaemia in rats. Eur Neuropsychopharmacol. 2007 Sep;17(9):600-7. PubMed PMID: 17363226.
108: Hurtado O, Cárdenas A, Pradillo JM, Morales JR, Ortego F, Sobrino T, Castillo J, Moro MA, Lizasoain I. A chronic treatment with CDP-choline improves functional recovery and increases neuronal plasticity after experimental stroke. Neurobiol Dis. 2007 Apr;26(1):105-11. PubMed PMID: 17234423.
107: Romera C, Hurtado O, Mallolas J, Pereira MP, Morales JR, Romera A, Serena J, Vivancos J, Nombela F, Lorenzo P, Lizasoain I, Moro MA. Ischemic preconditioning reveals that GLT1/EAAT2 glutamate transporter is a novel PPARgamma target gene involved in neuroprotection. J Cereb Blood Flow Metab. 2007 Jul;27(7):1327-38. PubMed PMID: 17213861.
106: Arenillas JF, Moro MA, Dávalos A. The metabolic syndrome and stroke: potential treatment approaches. Stroke. 2007 Jul;38(7):2196-203. PubMed PMID: 17540972.
105: Fernández-Velasco M, Ruiz-Hurtado G, Hurtado O, Moro MA, Delgado C. TNF-alpha downregulates transient outward potassium current in rat ventricular myocytes through iNOS overexpression and oxidant species generation. Am J Physiol HeartCirc Physiol. 2007 Jul;293(1):H238-45. PubMed PMID: 17337591.
104: Millan M, Sobrino T, Castellanos M, Nombela F, Arenillas JF, Riva E, Cristobo I, García MM, Vivancos J, Serena J, Moro MA, Castillo J, Dávalos A. Increased body iron stores are associated with poor outcome after thrombolytic treatment in acute stroke. Stroke. 2007 Jan;38(1):90-5. PubMed PMID: 17138950.
2006
103: Rodríguez-Yáñez M, Castellanos M, Blanco M, García MM, Nombela F, Serena J, Leira R, Lizasoain I, Dávalos A, Castillo J. New-onset hypertension and inflammatory response/poor outcome in acute ischemic stroke. Neurology. 2006 Dec 12;67(11):1973-8. PubMed PMID: 17159103.
102: Rodríguez-Yáñez M, Castellanos M, Blanco M, Millán M, Nombela F, Sobrino T, Lizasoain I, Leira R, Serena J, Dávalos A, Castillo J. Micro- and macroalbuminuria predict hemorrhagic transformation in acute ischemic stroke. Neurology. 2006 Oct 10;67(7):1172-7. PubMed PMID: 17030748.
101: Leira R, Rodríguez-Yáñez M, Castellanos M, Blanco M, Nombela F, Sobrino T, Lizasoain I, Dávalos A, Castillo J. Hyperthermia is a surrogate marker of inflammation-mediated cause of brain damage in acute ischaemic stroke. J Intern Med. 2006 Oct;260(4):343-9. PubMed PMID: 16961671.
100: Fernández-López D, Martínez-Orgado J, Nuñez E, Romero J, Lorenzo P, Moro MA, Lizasoain I. Characterization of the neuroprotective effect of the cannabinoid agonist WIN-55212 in an in vitro model of hypoxic-ischemic brain damage in newborn rats. Pediatr Res. 2006 Aug;60(2):169-73. PubMed PMID: 16864698.
99: Caso JR, Lizasoain I, Lorenzo P, Moro MA, Leza JC. The role of tumor necrosis factor-alpha in stress-induced worsening of cerebral ischemia in rats. Neuroscience. 2006 Sep 29;142(1):59-69. PubMed PMID: 16844305.
98: Blanco M, Castellanos M, Rodríguez-Yáñez M, Sobrino T, Leira R, Vivancos J, Lizasoain I, Serena J, Dávalos A, Castillo J. High blood pressure and inflammation are associated with poor prognosis in lacunar infarctions. Cerebrovasc Dis. 2006;22(2-3):123-9. PubMed PMID: 16691020.
97: Hurtado O, Pradillo JM, Alonso-Escolano D, Lorenzo P, Sobrino T, Castillo J, Lizasoain I, Moro MA. Neurorepair versus neuroprotection in stroke. CerebrovascDis. 2006;21 Suppl 2:54-63. PubMed PMID: 16651815.
96: Blanco M, Lizasoain I, Sobrino T, Vivancos J, Castillo J. Ischemic preconditioning: a novel target for neuroprotective therapy. Cerebrovasc Dis. 2006;21 Suppl 2:38-47. PubMed PMID: 16651813.
95: Lizasoain I, Cárdenas A, Hurtado O, Romera C, Mallolas J, Lorenzo P, Castillo J, Moro MA. Targets of cytoprotection in acute ischemic stroke: present and future. Cerebrovasc Dis. 2006;21 Suppl 2:1-8. PubMed PMID: 16651809.
94: Mallolas J, Hurtado O, Castellanos M, Blanco M, Sobrino T, Serena J, Vivancos J, Castillo J, Lizasoain I, Moro MA, Dávalos A. A polymorphism in the EAAT2 promoter is associated with higher glutamate concentrations and higher frequency of progressing stroke. J Exp Med. 2006 Mar 20;203(3):711-7. PubMed PMID: 16520390.
93: Comabella M, Romera C, Camiña M, Perkal H, Moro MA, Leza JC, Lizasoain I, Castillo M, Montalban X. TNF-alpha converting enzyme (TACE) protein expression in different clinical subtypes of multiple sclerosis. J Neurol. 2006 Jun;253(6):701-6. PubMed PMID: 16511637.
92: Pradillo JM, Hurtado O, Romera C, Cárdenas A, Fernández-Tomé P, Alonso-Escolano D, Lorenzo P, Moro MA, Lizasoain I. TNFR1 mediates increased neuronal membrane EAAT3 expression after in vivo cerebral ischemic preconditioning.Neuroscience. 2006;138(4):1171-8. PubMed PMID: 16442237.
91: Pereira MP, Hurtado O, Cárdenas A, Boscá L, Castillo J, Dávalos A, Vivancos J, Serena J, Lorenzo P, Lizasoain I, Moro MA. Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2 cause potent neuroprotection after experimental stroke through noncompletely overlapping mechanisms. J Cereb Blood Flow Metab. 2006 Feb;26(2):218-29. PubMed PMID: 16034372.
2005
90: Cárdenas A, Moro MA, Hurtado O, Leza JC, Lizasoain I. Dual role of nitric oxide in adult neurogenesis. Brain Res Brain Res Rev. 2005 Dec 1;50(1):1-6. PubMed PMID: 16291071.
89: Pereira MP, Hurtado O, Cárdenas A, Alonso-Escolano D, Boscá L, Vivancos J, Nombela F, Leza JC, Lorenzo P, Lizasoain I, Moro MA. The nonthiazolidinedione PPARgamma agonist L-796,449 is neuroprotective in experimental stroke. J Neuropathol Exp Neurol. 2005 Sep;64(9):797-805. PubMed PMID: 16141790.
88: Serena J, Blanco M, Castellanos M, Silva Y, Vivancos J, Moro MA, Leira R, Lizasoain I, Castillo J, Dávalos A. The prediction of malignant cerebral infarction by molecular brain barrier disruption markers. Stroke. 2005 Sep;36(9):1921-6. PubMed PMID: 16100032.
87: Fernández-López D, Martínez-Orgado J, Casanova I, Bonet B, Leza JC, Lorenzo P, Moro MA, Lizasoain I. Immature rat brain slices exposed to oxygen-glucose deprivation as an in vitro model of neonatal hypoxic-ischemic encephalopathy. JNeurosci Methods. 2005 Jun 30;145(1-2):205-12. PubMed PMID: 15922037.
86: Blanco M, Moro MA, Dávalos A, Leira R, Castellanos M, Serena J, Vivancos J, Rodríguez-Yáñez M, Lizasoain I, Castillo J. Increased plasma levels of 15-deoxyDelta prostaglandin J2 are associated with good outcome in acute atherothrombotic ischemic stroke. Stroke. 2005 Jun;36(6):1189-94. PubMed PMID: 15879329.
85: García-Bueno B, Madrigal JL, Lizasoain I, Moro MA, Lorenzo P, Leza JC. Peroxisome proliferator-activated receptor gamma activation decreases neuroinflammation in brain after stress in rats. Biol Psychiatry. 2005 Apr 15;57(8):885-94. PubMed PMID: 15820709.
84: García-Bueno B, Madrigal JL, Lizasoain I, Moro MA, Lorenzo P, Leza JC. The anti-inflammatory prostaglandin 15d-PGJ2 decreases oxidative/nitrosative mediators in brain after acute stress in rats. Psychopharmacology (Berl). 2005 Jul;180(3):513-22. PubMed PMID: 15719215.
83: Pérez-Asensio FJ, Hurtado O, Burguete MC, Moro MA, Salom JB, Lizasoain I, Torregrosa G, Leza JC, Alborch E, Castillo J, Knowles RG, Lorenzo P. Inhibition of iNOS activity by 1400W decreases glutamate release and ameliorates stroke outcome after experimental ischemia. Neurobiol Dis. 2005 Mar;18(2):375-84. PubMed PMID: 15686966.
82: Hurtado O, Moro MA, Cárdenas A, Sánchez V, Fernández-Tomé P, Leza JC, Lorenzo P, Secades JJ, Lozano R, Dávalos A, Castillo J, Lizasoain I. Neuroprotection afforded by prior citicoline administration in experimental brain ischemia: effects on glutamate transport. Neurobiol Dis. 2005 Mar;18(2):336-45. PubMed PMID: 15686962.
81: Pradillo JM, Romera C, Hurtado O, Cárdenas A, Moro MA, Leza JC, Dávalos A, Castillo J, Lorenzo P, Lizasoain I. TNFR1 upregulation mediates tolerance after brain ischemic preconditioning. J Cereb Blood Flow Metab. 2005 Feb;25(2):193-203. PubMed PMID: 15647744.
2004
80: Colón AL, Madrigal JL, Menchén LA, Moro MA, Lizasoain I, Lorenzo P, Leza JC. Stress increases susceptibility to oxidative/nitrosative mucosal damage in an experimental model of colitis in rats. Dig Dis Sci. 2004 Oct;49(10):1713-21. PubMed PMID: 15573932.
79: Menchén L, Colón AL, Madrigal JL, Beltrán L, Botella S, Lizasoain I, Leza JC, Moro MA, Menchén P, Cos E, Lorenzo P. Activity of inducible and neuronal nitric oxide synthases in colonic mucosa predicts progression of ulcerative colitis. Am J Gastroenterol. 2004 Sep;99(9):1756-64. PubMed PMID: 15330915.
78: Munhoz C, Madrigal JL, García-Bueno B, Pradillo JM, Moro MA, Lizasoain I, Lorenzo P, Scavone C, Leza JC. TNF-alpha accounts for short-term persistence of oxidative status in rat brain after two weeks of repeated stress. Eur J Neurosci. 2004 Aug;20(4):1125-30. PubMed PMID: 15305883.
77: Moro MA, Cárdenas A, Hurtado O, Leza JC, Lizasoain I. Role of nitric oxide after brain ischaemia. Cell Calcium. 2004 Sep-Oct;36(3-4):265-75. PubMed PMID: 15261482.
76: Romera C, Hurtado O, Botella SH, Lizasoain I, Cárdenas A, Fernández-Tomé P, Leza JC, Lorenzo P, Moro MA. In vitro ischemic tolerance involves upregulation of glutamate transport partly mediated by the TACE/ADAM17-tumor necrosis factor-alpha pathway. J Neurosci. 2004 Feb 11;24(6):1350-7. PubMed PMID: 14960606.
75: Orio L, O'Shea E, Sanchez V, Pradillo JM, Escobedo I, Camarero J, Moro MA, Green AR, Colado MI. 3,4-Methylenedioxymethamphetamine increases interleukin-1beta levels and activates microglia in rat brain: studies on the relationship with acute hyperthermia and 5-HT depletion. J Neurochem. 2004 Jun;89(6):1445-53. PubMed PMID: 15189347.
74: Sánchez-González DJ, Moro MA, Castillo-Henkel C, Herrera-González N, Hernández-Pando R, Larios-Medina FJ, Cobilt R, Blanco JA, Pedraza-Chaverrí J, Villanueva C. Ozone exposure induces iNOS expression and tyrosine nitration in rat aorta. Environ Toxicol Pharmacol. 2004 May;17(1):1-7. PubMed PMID: 21782706.
2003
73: Castillo J, Moro MA, Blanco M, Leira R, Serena J, Lizasoain I, Dávalos A. The release of tumor necrosis factor-alpha is associated with ischemic tolerance in human stroke. Ann Neurol. 2003 Dec;54(6):811-9. PubMed PMID: 14681891.
72: Lizasoain I, Leira R. [Experimental headache models]. Neurologia. 2003 Oct;18(8):452-61. Review. Spanish. PubMed PMID: 14615947.
71: Madrigal JL, García-Bueno B, Moro MA, Lizasoain I, Lorenzo P, Leza JC. Relationship between cyclooxygenase-2 and nitric oxide synthase-2 in rat cortex after stress. Eur J Neurosci. 2003 Sep;18(6):1701-5. PubMed PMID: 14511348.
70: Castillo J, Alvarez-Sabin J, Dávalos A, Diez-Tejedor E, Lizasoain I, Martínez-Vila E, Vivancos J, Zarranz JJ. [Consensus review. Pharmacological neuroprotection in cerebral ischemia: is it still a therapeutic option?]. Neurologia. 2003 Sep;18(7):368-84. PubMed PMID: 14505245.
69: Hurtado O, De Cristóbal J, Sánchez V, Lizasoain I, Cárdenas A, Pereira MP, Colado MI, Leza JC, Lorenzo P, Moro MA. Inhibition of glutamate release by delaying ATP fall accounts for neuroprotective effects of antioxidants in experimental stroke. FASEB J. 2003 Nov;17(14):2082-4. PubMed PMID: 14500556.
68: Armengou A, Hurtado O, Leira R, Obón M, Pascual C, Moro MA, Lizasoain I, Castillo J, Dávalos A. L-arginine levels in blood as a marker of nitric oxide-mediated brain damage in acute stroke: a clinical and experimental study. J Cereb Blood Flow Metab. 2003 Aug;23(8):978-84. PubMed PMID: 12902842.
67: Moro MA, Hurtado O, Cárdenas A, Romera C, Madrigal JL, Fernández-Tomé P, Leza JC, Lorenzo P, Lizasoain I. Expression and function of tumour necrosis factor-alpha-converting enzyme in the central nervous system. Neurosignals. 2003 Mar-Apr;12(2):53-8. PubMed PMID: 12876399.
66: Madrigal JL, Caso JR, de Cristóbal J, Cárdenas A, Leza JC, Lizasoain I, Lorenzo P, Moro MA. Effect of subacute and chronic immobilisation stress on the outcome of permanent focal cerebral ischaemia in rats. Brain Res. 2003 Jul 25;979(1-2):137-45. PubMed PMID: 12850580.
65: Madrigal JL, Moro MA, Lizasoain I, Lorenzo P, Fernández AP, Rodrigo J, Boscá L, Leza JC. Induction of cyclooxygenase-2 accounts for restraint stress-induced oxidative status in rat brain. Neuropsychopharmacology. 2003 Sep;28(9):1579-88. PubMed PMID: 12784118.
64: Castillo J, Leira R, Moro MA, Lizasoain I, Serena J, Dávalos A. Neuroprotective effects of aspirin in patients with acute cerebral infarction. Neurosci Lett. 2003 Mar 27;339(3):248-50. PubMed PMID: 12633899.
63: Castellanos M, Leira R, Serena J, Pumar JM, Lizasoain I, Castillo J, Dávalos A. Plasma metalloproteinase-9 concentration predicts hemorrhagic transformation in acute ischemic stroke. Stroke. 2003 Jan;34(1):40-6. PubMed PMID: 12511748.
2002
62: Cárdenas A, Moro MA, Leza JC, O'Shea E, Dávalos A, Castillo J, Lorenzo P, Lizasoain I. Upregulation of TACE/ADAM17 after ischemic preconditioning is involved in brain tolerance. J Cereb Blood Flow Metab. 2002 Nov;22(11):1297-302. PubMed PMID: 12439286.
61: Molina JA, Leza JC, Ortiz S, Moro MA, Pérez S, Lizasoaín I, Urigüen L, Oliva JM, Manzanares J. Cerebrospinal fluid and plasma concentrations of nitric oxide metabolites are increased in dementia with Lewy bodies. Neurosci Lett. 2002 Nov 22;333(2):151-3. PubMed PMID: 12419502.
60: Madrigal JL, Moro MA, Lizasoain I, Lorenzo P, Leza JC. Stress-induced increase in extracellular sucrose space in rats is mediated by nitric oxide. Brain Res. 2002 May 31;938(1-2):87-91. PubMed PMID: 12031539.
59: Hurtado O, Lizasoain I, Fernández-Tomé P, Alvarez-Barrientos A, Leza JC, Lorenzo P, Moro MA. TACE/ADAM17-TNF-alpha pathway in rat cortical cultures after exposure to oxygen-glucose deprivation or glutamate. J Cereb Blood Flow Metab. 2002 May;22(5):576-85. PubMed PMID: 11973430.
58: De Cristóbal J, Madrigal JL, Lizasoain I, Lorenzo P, Leza JC, Moro MA. Aspirin inhibits stress-induced increase in plasma glutamate, brain oxidative damage and ATP fall in rats. Neuroreport. 2002 Feb 11;13(2):217-21. PubMed PMID: 11893913.
57: Madrigal JL, Hurtado O, Moro MA, Lizasoain I, Lorenzo P, Castrillo A, Boscá L, Leza JC. The increase in TNF-alpha levels is implicated in NF-kappaB activation and inducible nitric oxide synthase expression in brain cortex after immobilization stress. Neuropsychopharmacology. 2002 Feb;26(2):155-63. PubMed PMID: 11790511.
56: De Cristóbal J, Cárdenas A, Lizasoain I, Leza JC, Fernández-Tomé P, Lorenzo P, Moro MA. Inhibition of glutamate release via recovery of ATP levels accounts for a neuroprotective effect of aspirin in rat cortical neurons exposed to oxygen-glucose deprivation. Stroke. 2002 Jan;33(1):261-7. PubMed PMID: 11779920.
2001
55: Colón AL, Menchén LA, Hurtado O, De Cristóbal J, Lizasoain I, Leza JC, Lorenzo P, Moro MA. Implication of TNF-alpha convertase (TACE/ADAM17) in inducible nitric oxide synthase expression and inflammation in an experimental model of colitis. Cytokine. 2001 Dec 21;16(6):220-6. PubMed PMID: 11884025.
54: De Cristóbal J, Moro MA, Dávalos A, Castillo J, Leza JC, Camarero J, Colado MI, Lorenzo P, Lizasoain I. Neuroprotective effect of aspirin by inhibition of glutamate release after permanent focal cerebral ischaemia in rats. J Neurochem. 2001 Oct;79(2):456-9. PubMed PMID: 11677274.
53: Diez-Orejas R, Molero G, Moro MA, Gil C, Nombela C, Sánchez-Pérez M. Two different NO-dependent mechanisms account for the low virulence of a non-mycelial morphological mutant of Candida albicans. Med Microbiol Immunol. 2001 Apr;189(3):153-60. PubMed PMID: 11388613.
52: Menchén LA, Colón AL, Moro MA, Leza JC, Lizasoain I, Menchén P, Alvarez E, Lorenzo P. N-(3-(aminomethyl)benzyl)acetamidine, an inducible nitric oxide synthase inhibitor, decreases colonic inflammation induced by trinitrobenzene sulphonic acid in rats. Life Sci. 2001 Jun 15;69(4):479-91. PubMed PMID: 11459438.
51: Hurtado O, Cárdenas A, Lizasoain I, Boscá L, Leza JC, Lorenzo P, Moro MA. Up-regulation of TNF-alpha convertase (TACE/ADAM17) after oxygen-glucose deprivation in rat forebrain slices. Neuropharmacology. 2001 Jun;40(8):1094-102. PubMed PMID: 11406201.
50: Madrigal JL, Moro MA, Lizasoain I, Lorenzo P, Castrillo A, Boscá L, Leza JC. Inducible nitric oxide synthase expression in brain cortex after acute restraint stress is regulated by nuclear factor kappaB-mediated mechanisms. J Neurochem. 2001 Jan;76(2):532-8. PubMed PMID: 11208916.
49: Madrigal JL, Olivenza R, Moro MA, Lizasoain I, Lorenzo P, Rodrigo J, Leza JC. Glutathione depletion, lipid peroxidation and mitochondrial dysfunction are induced by chronic stress in rat brain. Neuropsychopharmacology. 2001 Apr;24(4):420-9. PubMed PMID: 11182537.
2000
48: Cárdenas A, Hurtado O, Leza JC, Lorenzo P, Bartrons R, Lizasoain I, Moro MA. Fructose-1,6-bisphosphate inhibits the expression of inducible nitric oxide synthase caused by oxygen-glucose deprivation through the inhibition of glutamate release in rat forebrain slices. Naunyn Schmiedebergs Arch Pharmacol. 2000 Sep;362(3):208-12. PubMed PMID: 10997722.
47: Colón AL, Menchén L, Lizasoain I, Leza JC, Menchén P, González-Lara V, Moro MA, Lorenzo P. Inducible nitric oxide synthase activity is expressed not only in inflamed but also in normal colonic mucosa in patients with ulcerative colitis: a potential prognostic marker. Am J Gastroenterol. 2000 May;95(5):1371-3. PubMed PMID: 10811365.
46: Cárdenas A, Moro MA, Hurtado O, Leza JC, Lorenzo P, Castrillo A, Bodelón OG, Boscá L, Lizasoain I. Implication of glutamate in the expression of inducible nitric oxide synthase after oxygen and glucose deprivation in rat forebrain slices. J Neurochem. 2000 May;74(5):2041-8. PubMed PMID: 10800947.
45: Moro MA, De Alba J, Cárdenas A, De Cristóbal J, Leza JC, Lizasoain I, Díaz-Guerra MJ, Boscá L, Lorenzo P. Mechanisms of the neuroprotective effect of aspirin after oxygen and glucose deprivation in rat forebrain slices. Neuropharmacology. 2000 Apr 27;39(7):1309-18. PubMed PMID: 10760373.
44: Cuéllar B, Fernández AP, Lizasoain I, Moro MA, Lorenzo P, Bentura ML, Rodrigo J, Leza JC. Up-regulation of neuronal NO synthase immunoreactivity in opiate dependence and withdrawal. Psychopharmacology (Berl). 2000 Jan;148(1):66-73. PubMed PMID: 10663419.
43: Olivenza R, Moro MA, Lizasoain I, Lorenzo P, Fernández AP, Rodrigo J, Boscá L, Leza JC. Chronic stress induces the expression of inducible nitric oxide synthase in rat brain cortex. J Neurochem. 2000 Feb;74(2):785-91. PubMed PMID: 10646531.
1999
42: Fernández-Tomé P, Lizasoain I, Leza JC, Lorenzo P, Moro MA. Neuroprotective effects of DETA-NONOate, a nitric oxide donor, on hydrogen peroxide-induced neurotoxicity in cortical neurones. Neuropharmacology. 1999 Sep;38(9):1307-15. PubMed PMID: 10471084.
41: De Alba J, Cárdenas A, Moro MA, Leza JC, Lorenzo P, Lizasoain I. Use of brain slices in the study of pathogenic role of inducible nitric oxide synthase in cerebral ischemia-reperfusion. Gen Pharmacol. 1999 May;32(5):577-81. PubMed PMID: 10382860.
40: Gavilanes J, Moro MA, Lizasoain I, Lorenzo P, Pérez A, Leza JC, Alvarez-Vicent JJ. Nitric oxide synthase activity in human squamous cell carcinoma of the head and neck. Laryngoscope. 1999 Jan;109(1):148-52. PubMed PMID: 9917057.
39: De Alba J, Cárdenas A, Moro MA, Leza JC, Lorenzo P, Boscá L, Lizasoain I. Down-regulation of neuronal nitric oxide synthase by nitric oxide after oxygen-glucose deprivation in rat forebrain slices. J Neurochem. 1999 Jan;72(1):248-54. PubMed PMID: 9886076.
1998
38: Moro MA, Fernández-Tomé P, Leza JC, Lorenzo P, Lizasoain I. Neuronal death induced by SIN-1 in the presence of superoxide dismutase: protection by cyclic GMP. Neuropharmacology. 1998 Aug;37(8):1071-9. PubMed PMID: 9833636.
37: Lizasoain I, Moro MA. Simultaneous measurement of mitochondrial function and NO. Methods Mol Biol. 1998;100:273-9. PubMed PMID: 10907013.
36: Uttenthal LO, Alonso D, Fernández AP, Campbell RO, Moro MA, Leza JC, Lizasoain I, Esteban FJ, Barroso JB, Valderrama R, Pedrosa JA, Peinado MA, Serrano J, Richart A, Bentura ML, Santacana M, Martínez-Murillo R, Rodrigo J. Neuronal and inducible nitric oxide synthase and nitrotyrosine immunoreactivities in the cerebral cortex of the aging rat. Microsc Res Tech. 1998 Oct 1;43(1):75-88. PubMed PMID: 9829462.
35: Brown AS, Moro MA, Masse JM, Cramer EM, Radomski M, Darley-Usmar V. Nitric oxide-dependent and independent effects on human platelets treated with peroxynitrite. Cardiovasc Res. 1998 Nov;40(2):380-8. PubMed PMID: 9893732.
34: Cárdenas A, De Alba J, Moro MA, Leza JC, Lorenzo P, Lizasoain I. Protective effect of N-(3-(aminomethyl)benzyl) acetamidine, an inducible nitric oxide synthase inhibitor, in brain slices exposed to oxygen-glucose deprivation. Eur J Pharmacol. 1998 Aug 7;354(2-3):161-5. PubMed PMID: 9754916.
33: Moro MA, De Alba J, Leza JC, Lorenzo P, Fernández AP, Bentura ML, Boscá L, Rodrigo J, Lizasoain I. Neuronal expression of inducible nitric oxide synthase after oxygen and glucose deprivation in rat forebrain slices. Eur J Neurosci. 1998 Feb;10(2):445-56. PubMed PMID: 9749707.
32: Moro MA, Leza JC, Lorenzo P, Lizasoain I. Peroxynitrite causes aspartate release from dissociated rat cerebellar granule neurones. Free Radic Res. 1998 Feb;28(2):193-204. PubMed PMID: 9645395.
1996
31: Lizasoain I, Weiner CP, Knowles RG, Moncada S. The ontogeny of cerebral and cerebellar nitric oxide synthase in the guinea pig and rat. Pediatr Res. 1996 May;39(5):779-83. PubMed PMID: 8726228.
30: Lizasoain I, Leza JC, Cuéllar B, Moro MA, Lorenzo P. Inhibition of morphine withdrawal by lamotrigine: involvement of nitric oxide. Eur J Pharmacol. 1996 Mar 28;299(1-3):41-5. PubMed PMID: 8901006.
29: Charles IG, Scorer CA, Moro MA, Fernàndez C, Chubb A, Dawson J, Foxwell N, Knowles RG, Baylis SA. Expression of human nitric oxide synthase isozymes. Methods Enzymol. 1996;268:449-60. PubMed PMID: 8782611.
28: Lizasoain I, Moro MA, Knowles RG, Darley-Usmar V, Moncada S. Nitric oxide and peroxynitrite exert distinct effects on mitochondrial respiration which are differentially blocked by glutathione or glucose. Biochem J. 1996 Mar 15;314 ( Pt3):877-80. PubMed PMID: 8615783.
27: Moro MA, Russel RJ, Cellek S, Lizasoain I, Su Y, Darley-Usmar VM, Radomski MW, Moncada S. cGMP mediates the vascular and platelet actions of nitric oxide: confirmation using an inhibitor of the soluble guanylyl cyclase. Proc Natl Acad Sci U S A. 1996 Feb 20;93(4):1480-5. PubMed PMID: 8643658.
26: San-Martin-Clark O, Cuellar B, Leza JC, Lizasoain I, Lorenzo P. Effects of trepelennamine on brain monoamine turnover in morphine dependent and abstinent mice. Psychopharmacology (Berl). 1996 Feb;123(3):297-302. PubMed PMID: 8833423.
25: Leza JC, Lizasoain I, Cuéllar B, Moro MA, Lorenzo P. Correlation between brain nitric oxide synthase activity and opiate withdrawal. Naunyn Schmiedebergs Arch Pharmacol. 1996 Feb;353(3):349-54. PubMed PMID: 8692292.
1995
24: Leza JC, Lizasoain I, San-Martín-Clark O, Lorenzo P. Morphine-induced changes in cerebral and cerebellar nitric oxide synthase activity. Eur J Pharmacol. 1995 Oct 4;285(1):95-8. PubMed PMID: 8846816.
23: Moro MA, Darley-Usmar VM, Lizasoain I, Su Y, Knowles RG, Radomski MW, Moncada S. The formation of nitric oxide donors from peroxynitrite. Br JPharmacol. 1995 Oct;116(3):1999-2004. PubMed PMID: 8640338.
22: Lizasoain I, Knowles RG, Moncada S. Inhibition by lamotrigine of the generation of nitric oxide in rat forebrain slices. J Neurochem. 1995 Feb;64(2):636-42. PubMed PMID: 7830056.
1994
21: Weiner CP, Lizasoain I, Baylis SA, Knowles RG, Charles IG, Moncada S. Induction of calcium-dependent nitric oxide synthases by sex hormones. Proc Natl Acad Sci U S A. 1994 May 24;91(11):5212-6. PubMed PMID: 7515189.
20: Shahbazi T, Jones N, Radomski MW, Moro MA, Gingell D. Nitric oxide donors inhibit platelet spreading on surfaces coated with fibrinogen but not with fibronectin. Thromb Res. 1994 Sep 15;75(6):631-42. PubMed PMID: 7831682.
19: Salas E, Moro MA, Askew S, Hodson HF, Butler AR, Radomski MW, Moncada S. Comparative pharmacology of analogues of S-nitroso-N-acetyl-DL-penicillamine on human platelets. Br J Pharmacol. 1994 Aug;112(4):1071-6. PubMed PMID: 7524991.
18: Moro MA, Darley-Usmar VM, Goodwin DA, Read NG, Zamora-Pino R, Feelisch M, Radomski MW, Moncada S. Paradoxical fate and biological action of peroxynitrite on human platelets. Proc Natl Acad Sci U S A. 1994 Jul 5;91(14):6702-6. PubMed PMID: 7517561.
1993
17: San-Martin-Clark O, Leza JC, Lizasoain I, Lorenzo P. Changes induced by sodium cromoglycate on brain serotonin turnover in morphine dependent and abstinent mice. Psychopharmacology (Berl). 1993;111(2):233-8. PubMed PMID: 7532863.
16: Moro MA, Michelena P, Sánchez-García P, Palmer R, Moncada S, García AG. Activation of adrenal medullary L-arginine: nitric oxide pathway by stimuli which induce the release of catecholamines. Eur J Pharmacol. 1993 Aug 15;246(3):213-8. PubMed PMID: 7693497.
1992
15: Leza JC, Lizasoain I, Martín-Clark OS, Lorenzo P. Role of sodium cromoglycate on analgesia, locomotor activity and opiate withdrawal in mice. Psychopharmacology (Berl). 1992;107(4):595-600. PubMed PMID: 1376478.
14: Castillo CJ, Moro MA, Del Valle M, Sillero A, García AG, Sillero MA. Diadenosine tetraphosphate is co-released with ATP and catecholamines from bovine adrenal medulla. J Neurochem. 1992 Aug;59(2):723-32. PubMed PMID: 1629742.
1991
13: Navarro M, Lizasoain I, Leza JC, Lorenzo P. An original method for assessment of the jumping test. Methods Find Exp Clin Pharmacol. 1991 Sep;13(7):443-7. PubMed PMID: 1784140.
12: Lizasoain I, Leza JC, Lorenzo P. Buprenorphine: bell-shaped dose-response curve for its antagonist effects. Gen Pharmacol. 1991;22(2):297-300. PubMed PMID: 2055424.
11: Navarro M, Leza JC, Lizasoain I, Lorenzo P. Influence of psychogenetics in opiate tolerance and abstinence in mice. Gen Pharmacol. 1991;22(4):713-6. PubMed PMID: 1936907.
10: Leza JC, Lizasoain I, Lorenzo P. Effects of antihistaminics on locomotor activity in mice. Comparison with opiate and amphetamine-induced hyperactivity. Gen Pharmacol. 1991;22(2):293-6. PubMed PMID: 1676005.
9: Moro MA, Garcia AG, Langley OK. Characterization of two chromaffin cell populations isolated from bovine adrenal medulla. J Neurochem. 1991 Aug;57(2):363-9. PubMed PMID: 2072090.
8: Michelena P, Moro MA, Castillo CJ, García AG. Muscarinic receptors in separate populations of noradrenaline- and adrenaline-containing chromaffin cells. Biochem Biophys Res Commun. 1991 Jun 28;177(3):913-9. PubMed PMID: 2059218.
1990
7: Leza JC, Lizasoain I, Lorenzo P. H1- and H2-histamine receptor blockers and opiate analgesia in mice. Methods Find Exp Clin Pharmacol. 1990 Dec;12(10):671-8. PubMed PMID: 1983158.
6: Martin MI, Lizasoain I, Leza JC. Calcium channel blockers: effect on morphine-induced hypermotility. Psychopharmacology (Berl). 1990;101(2):267-70. PubMed PMID: 2349368.
5: Leza JC, Lizasoain I, Lorenzo P. Effects of antihistaminics on naloxone-induced withdrawal in morphine-dependent mice. Psychopharmacology (Berl). 1990;102(1):106-11. PubMed PMID: 1975446.
4: Garrido B, López MG, Moro MA, de Pascual R, García AG. Voltage-dependent inactivation of catecholamine secretion evoked by brief calcium pulses in the cat adrenal medulla. J Physiol. 1990 Sep;428:615-37. PubMed PMID: 1700112.
3: Moro MA, López MG, Gandía L, Michelena P, García AG. Separation and culture of living adrenaline- and noradrenaline-containing cells from bovine adrenal medullae. Anal Biochem. 1990 Mar;185(2):243-8. PubMed PMID: 2339781.
1989
2: López MG, Moro MA, Castillo CF, Artalejo CR, García AG. Variable, voltage-dependent, blocking effects of nitrendipine, verapamil, diltiazem, cinnarizine and cadmium on adrenomedullary secretion. Br J Pharmacol. 1989 Mar;96(3):725-31. PubMed PMID: 2720300.
1988
1: Artalejo CR, López MG, Moro MA, Castillo CF, de Pascual R, García AG. Voltage-dependence of nitrendipine provides direct evidence for dihydropyridine receptor coupling to calcium channels in intact cat adrenals. Biochem Biophys ResCommun. 1988 Jun 30;153(3):912-8. PubMed PMID: 2455516.